The Genetic and Clinical Features of FOXL2-Related Blepharophimosis, Ptosis and Epicanthus Inversus Syndrome
- PMID: 33806295
- PMCID: PMC7998575
- DOI: 10.3390/genes12030364
The Genetic and Clinical Features of FOXL2-Related Blepharophimosis, Ptosis and Epicanthus Inversus Syndrome
Abstract
Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) is a craniofacial disorder caused by heterozygous variants of the forkhead box L2 (FOXL2) gene. It shows autosomal dominant inheritance but can also occur sporadically. Depending on the mutation, two phenotypic subtypes have been described, both involving the same craniofacial features: type I, which is associated with premature ovarian failure (POF), and type II, which has no systemic features. The genotype-phenotype correlation is not fully understood, but it has been hypothesised that type I BPES involves more severe loss of function variants spanning the whole gene. Type II BPES has been linked to frameshift mutations that result in elongation of the protein rather than complete loss of function. A mutational hotspot has been identified within the poly-alanine domain, although the exact function of this region is still unknown. However, the BPES subtype cannot be determined genetically, necessitating informed genetic counselling and careful discussion of family planning advice in view of the associated POF particularly as the patient may still be a child. Following puberty, female patients should be referred for ovarian reserve and response assessment. Oculofacial features can be managed with surgical intervention and regular monitoring to prevent amblyopia.
Keywords: BPES I; BPES II; FOXL2; blepharophimosis; epicanthus inversus; premature ovarian failure; ptosis.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures


Similar articles
-
Clinical characterization and identification of five novel FOXL2 pathogenic variants in a cohort of 12 Mexican subjects with the syndrome of blepharophimosis-ptosis-epicanthus inversus.Gene. 2019 Jul 20;706:62-68. doi: 10.1016/j.gene.2019.04.073. Epub 2019 Apr 29. Gene. 2019. PMID: 31048069
-
Identification of a novel FOXL2 mutation in a single family with both types of blepharophimosis‑-ptosis-epicanthus inversus syndrome.Mol Med Rep. 2017 Oct;16(4):5529-5532. doi: 10.3892/mmr.2017.7226. Epub 2017 Aug 10. Mol Med Rep. 2017. PMID: 28849110
-
Premature ovarian insufficiency as a variable feature of blepharophimosis, ptosis, and epicanthus inversus syndrome associated with c.223C > T p.(Leu75Phe) FOXL2 mutation: a case report.BMC Med Genet. 2019 Jul 31;20(1):132. doi: 10.1186/s12881-019-0865-0. BMC Med Genet. 2019. PMID: 31366388 Free PMC article.
-
Premature ovarian failure and forkhead transcription factor FOXL2: blepharophimosis-ptosis-epicanthus inversus syndrome and ovarian dysfunction.Pediatr Endocrinol Rev. 2005 Jun;2(4):653-60. Pediatr Endocrinol Rev. 2005. PMID: 16208278 Review.
-
[Blepharophimosis ptosis epicanthus inversus syndrome (BPES) (corrected)].Klin Monbl Augenheilkd. 2012 Jan;229(1):28-30. doi: 10.1055/s-0031-1281864. Epub 2012 Jan 12. Klin Monbl Augenheilkd. 2012. PMID: 22241538 Review. German.
Cited by
-
Current understanding of the genomic abnormities in premature ovarian failure: chance for early diagnosis and management.Front Med (Lausanne). 2023 Jun 2;10:1194865. doi: 10.3389/fmed.2023.1194865. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37332766 Free PMC article. Review.
-
Blepharophimosis, Ptosis, and Epicanthus Inversus Syndrome: A Simple Remedy for Challenging Cases.Cureus. 2022 Jul 29;14(7):e27432. doi: 10.7759/cureus.27432. eCollection 2022 Jul. Cureus. 2022. PMID: 36051713 Free PMC article.
-
Expanded phenotypic spectrum of FOXL2 Variant c.672_701dup revealed by whole-exome sequencing in a rare blepharophimosis, ptosis, and epicanthus inversus syndrome family.BMC Ophthalmol. 2023 Nov 7;23(1):446. doi: 10.1186/s12886-023-03189-5. BMC Ophthalmol. 2023. PMID: 37932670 Free PMC article.
-
Ovarian Reserve and ART Outcomes in Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Patients With FOXL2 Mutations.Front Endocrinol (Lausanne). 2022 Apr 28;13:829153. doi: 10.3389/fendo.2022.829153. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35574016 Free PMC article.
-
Case Report: Blepharophimosis and Ptosis as Leading Dysmorphic Features of Rare Congenital Malformation Syndrome With Developmental Delay - New Cases With TRAF7 Variants.Front Med (Lausanne). 2021 Aug 26;8:708717. doi: 10.3389/fmed.2021.708717. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34513876 Free PMC article.
References
-
- Chawla B., Bhadange Y., Dada R., Kumar M., Sharma S., Bajaj M.S., Pushker N., Chandra M., Ghose S. Clinical, Radiologic, and Genetic Features in Blepharophimosis, Ptosis, and Epicanthus Inversus Syndrome in the Indian Population. Investig. Opthalmol. Vis. Sci. 2013;54:2985–2991. doi: 10.1167/iovs.13-11794. - DOI - PubMed
-
- Chen H. Atlas of Genetic Diagnosis and Counseling. Springer; New York, NY, USA: 2012. Blepharophimosis, Ptosis, and Epicanthus Inversus Syndrome; pp. 233–238. - DOI
-
- Beysen D., Raes J., Leroy B.P., Lucassen A., Yates J.R.W., Clayton-Smith J., Ilyina H., Brooks S.S., Christin-Maitre S., Fellous M., et al. Deletions Involving Long-Range Conserved Nongenic Sequences Upstream and Downstream of FOXL2 as a Novel Disease-Causing Mechanism in Blepharophimosis Syndrome. Am. J. Hum. Genet. 2005;77:205–218. doi: 10.1086/432083. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical